Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

被引:29
作者
Rossello, Xavier [1 ,2 ]
Dorresteijn, Jannick A. N. [3 ]
Janssen, Arne [4 ]
Lambrinou, Ekaterini [4 ,5 ]
Scherrenberg, Martijn [6 ,7 ]
Bonnefoy-Cudraz, Eric [8 ]
Cobain, Mark [9 ]
Piepoli, Massimo F. [10 ,11 ]
Visseren, Frank L. J. [2 ]
Dendale, Paul [6 ,7 ]
机构
[1] CNIC, Madrid, Spain
[2] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain
[3] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands
[4] Jessa Hosp, Heartctr Hasselt, Clin Res Dept Cardiol, Hasselt, Belgium
[5] Cyprus Univ Technol, Dept Nursing, Limassol, Cyprus
[6] Jessa Hosp, Heartctr Hasselt, Hasselt, Belgium
[7] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium
[8] Hop Cardiol Lyon, Dept Cardiol, Lyon, France
[9] Imperial Coll, Dept Cardiovasc Med, London, England
[10] Guglielmo da Saliceto Hosp, Heart Failure Unit, Cardiol, Piacenza, Italy
[11] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
关键词
Risk prediction; risk assessment; cardiovascular disease; prevention; patient; ACUTE HEART-FAILURE; SECONDARY PREVENTION; VASCULAR-DISEASE; DECISION-MAKING; VALIDATION; MODEL; SCORE; METAANALYSIS; MORTALITY; SURVIVAL;
D O I
10.1177/1474515119856207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Risk assessment have become essential in the prevention of cardiovascular disease. Even though risk prediction tools are recommended in the European guidelines, they are not adequately implemented in clinical practice. Risk prediction tools are meant to estimate prognosis in an unbiased and reliable way and to provide objective information on outcome probabilities. They support informed treatment decisions about the initiation or adjustment of preventive medication. Risk prediction tools facilitate risk communication to the patient and their family, and this may increase commitment and motivation to improve their health. Over the years many risk algorithms have been developed to predict 10-year cardiovascular mortality or lifetime risk in different populations, such as in healthy individuals, patients with established cardiovascular disease and patients with diabetes mellitus. Each risk algorithm has its own limitations, so different algorithms should be used in different patient populations. Risk algorithms are made available for use in clinical practice by means of - usually interactive and online available - tools. To help the clinician to choose the right tool for the right patient, a summary of available tools is provided. When choosing a tool, physicians should consider medical history, geographical region, clinical guidelines and additional risk measures among other things. Currently, the U-prevent.com website is the only risk prediction tool providing prediction algorithms for all patient categories, and its implementation in clinical practice is suggested/advised by the European Association of Preventive Cardiology.
引用
收藏
页码:534 / 544
页数:11
相关论文
共 57 条
[1]  
[Anonymous], 2014, AM J CLIN NUTR S1, V100, p394S
[2]   Predictive accuracy of risk factors and markers: a simulation study of the effect of novel markers on different performance measures for logistic regression models [J].
Austin, Peter C. ;
Steyerberg, Ewout W. .
STATISTICS IN MEDICINE, 2013, 32 (04) :661-672
[3]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[4]   Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus [J].
Berkelmans, Gijs F. N. ;
Gudbjornsdottir, Soffia ;
Visseren, Frank L. J. ;
Wild, Sarah H. ;
Franzen, Stefan ;
Chalmers, John ;
Davis, Barry R. ;
Poulter, Neil R. ;
Spijkerman, Annemieke M. ;
Woodward, Mark ;
Pressel, Sara L. ;
Gupta, Ajay K. ;
van der Schouw, Yvonne T. ;
Svensson, Ann-Marie ;
van der Graaf, Yolanda ;
Read, Stephanie H. ;
Eliasson, Bjorn ;
Dorresteijn, Jannick An .
EUROPEAN HEART JOURNAL, 2019, 40 (34) :2899-+
[5]  
Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1
[6]   Use and misuse of the receiver operating characteristic curve in risk prediction [J].
Cook, Nancy R. .
CIRCULATION, 2007, 115 (07) :928-935
[7]   Cardiovascular risk estimation in older persons: SCORE OP [J].
Cooney, Marie Therese ;
Selmer, Randi ;
Lindman, Anja ;
Tverdal, Aage ;
Menotti, Alessandro ;
Thomsen, Troels ;
DeBacker, Guy ;
De Bacquer, Dirk ;
Tell, Grethe S. ;
Njolstad, Inger ;
Graham, Ian M. .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (10) :1093-1103
[8]   Cardiovascular Risk-Estimation Systems in Primary Prevention Do They Differ? Do They Make a Difference? Can We See the Future? [J].
Cooney, Marie Therese ;
Dudina, Alexandra ;
D'Agostino, Ralph ;
Graham, Ian M. .
CIRCULATION, 2010, 122 (03) :300-310
[9]   Index Event Bias as an Explanation for the Paradoxes of Recurrence Risk Research [J].
Dahabreh, Issa J. ;
Kent, David M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (08) :822-823
[10]   How to translate clinical trial results into gain in healthy life expectancy for individual patients [J].
Dorresteijn, Jannick A. N. ;
Kaasenbrood, Lotte ;
Cook, Nancy R. ;
van Kruijsdijk, Rob C. M. ;
van der Graaf, Yolanda ;
Visseren, Frank L. J. ;
Ridker, Paul M. .
BMJ-BRITISH MEDICAL JOURNAL, 2016, 352